16.
Pringle B, Dahlquist LM, Eskenazi A. Memory in pediatric patients undergoing conscious sedation for aversive medical procedures. Health Psychol. 2003;22(3):263–9.PubMed
17.
Henry DW, Burwinkle JW, Klutman NE. Determination of sedative and amnestic doses of lorazepam in children. Clin Pharm. 1991;10(8):625–9.PubMed
18.
Kennedy RM, Porter FL, Miller JP, Jaffe DM. Comparison of fentanyl/midazolam with ketamine/midazolam for pediatric orthopedic emergencies. Pediatrics. 1998;102(4 Pt 1):956–63.PubMed
19.
Smith MC, Williamson J, Yaster M, Boyd GJ, Heitmiller ES. Off-label use of medications in children undergoing sedation and anesthesia. Anesth Analg. 2012;115(5):1148–54.PubMed
20.
Mathis LL, Yao LP. Pediatric sedatives and the food and drug administration: challenges, limitations, and drugs in development. In: Mason K, editor. Pediatric sedation outside of the operating room: a multispecialty collaboration. 2nd ed. New York: Springer; 2015, p. 539–548.
21.
22.
American Academy of Pediatrics, Committee on Drugs. Alternative routes of drug administration—advantages and disadvantages (subject review). Pediatrics. 1997;100(1):143–52.
23.
American Academy of Pediatrics Committee on Drugs. Policy statement: off-label use of drugs in children. Pediatrics. 2014;133(3):563–7.
24.
Soriano SG, Vutskits L. Is there evidence for long-term neurocognitive effects of sedatives? In: Mason K, editor. Pediatric sedation outside of the operating room: a multispecialty collaboration. 2nd ed. New York: Springer; 2015, p. 549–552.
Alfentanil
25.
Brenchley J, Ramlakhan S. Intranasal alfentanil for acute pain in children. Emerg Med J. 2006;23(6):488.PubMedPubMedCentral
26.
Schwagmeier R, Boerger N, Meissner W, Striebel HW. Pharmacokinetics of intranasal alfentanil. J Clin Anesth. 1995;7(2):109–13.PubMed
28.
Baririan N, Van Obbergh L, Desager JP, Verbeeck RK, Wallemacq P, Starkel P, et al. Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis. Clin Pharmacokinet. 2007;46(3):261–70.PubMed
29.
Fiset P, Mathers L, Engstrom R, Fitzgerald D, Brand SC, Hsu F, et al. Pharmacokinetics of computer-controlled alfentanil administration in children undergoing cardiac surgery. Anesthesiology. 1995;83(5):944–55.PubMed
30.
den Hollander JM, Hennis PJ, Burm AG, Vletter AA, Bovill JG. Pharmacokinetics of alfentanil before and after cardiopulmonary bypass in pediatric patients undergoing cardiac surgery: part I. J Cardiothorac Vasc Anesth. 1992;6(3):308–12.
31.
Marlow N, Weindling AM, Van Peer A, Heykants J. Alfentanil pharmacokinetics in preterm infants. Arch Dis Child. 1990;65(4 Spec No):349–51.PubMedPubMedCentral
32.
Davis PJ, Stiller RL, Cook DR, Brandom BW, Davis JE, Scierka AM. Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children. Anesth Analg. 1989;68(5):579–83.PubMed
33.
Davis PJ, Killian A, Stiller RL, Cook DR, Guthrie RD, Scierka AM. Pharmacokinetics of alfentanil in newborn premature infants and older children. Dev Pharmacol Ther. 1989;13(1):21–7.PubMed
34.
den Hollander JM, Hennis PJ, Burm AG, Bovill JG. Alfentanil in infants and children with congenital heart defects. J Cardiothorac Anesth. 1988;2(1):12–7.
35.
Roure P, Jean N, Leclerc AC, Cabanel N, Levron JC, Duvaldestin P. Pharmacokinetics of alfentanil in children undergoing surgery. Br J Anaesth. 1987;59(11):1437–40.PubMed
36.
Goresky GV, Koren G, Sabourin MA, Sale JP, Strunin L. The pharmacokinetics of alfentanil in children. Anesthesiology. 1987;67(5):654–9.PubMed
37.
Meistelman C, Saint-Maurice C, Lepaul M, Levron JC, Loose JP, Mac Gee K. A comparison of alfentanil pharmacokinetics in children and adults. Anesthesiology. 1987;66(1):13–6.PubMed
38.
Van Peer A, Levron JC, Noorduin H, Heykants J. Overview of the clinical pharmacokinetics of alfentanil. Acta Anaesthesiol Belg. 1984;35(Suppl):261–3.PubMed
39.
Gutstein HB, Akil H. Opioid analgesics. In: Brunton LL, Lzo JS, Parker KL, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. p. 547–90.
Chloral Hydrate
40.
Lovinger DM, Zimmerman SA, Levitin M, et al. Trichloroethanol potentiates synaptic transmission mediated by g-aminobutyric acid receptors in hippocampal neurons. J Pharmacol Exp Ther. 1993;264:1097–103.PubMed
41.
Treluyer JM, Andre C, Carp PF, Chalumeau M, Tonnelier S, Cuq C, et al. Sedation in children undergoing CT scan or MRI: effect of time-course and tolerance of rectal chloral hydrate. Fundam Clin Pharmacol. 2004;18(3):347–50.PubMed
42.
Sakaguchi M, Inouye S. Anaphylaxis to gelatin-containing rectal suppositories. J Allergy Clin Immunol. 2001;108(6):1033–4.PubMed
43.
Dacher JN, Neuenschwander S, Monroc M, Vanier A, Eurin D, Le Dosseur P. Sedation with oral hydroxyzine and rectal chloral hydrate in pediatric MRI and CT. J Radiol. 1996;77(12):1189–92; discussion 1193–4 (article in French).PubMed
44.
Moody Jr EH, Mourino AP, Campbell RL. The therapeutic effectiveness of nitrous oxide and chloral hydrate administered orally, rectally, and combined with hydroxyzine for pediatric dentistry. ASDC J Dent Child. 1986;53(6):425–9.PubMed
45.
Baselt RC. Disposition of toxic drugs and chemicals in man. 7th ed. Foster City: Biomedical; 2004.
46.
Mayers DJ, Hindmarsh KW, Sankaran K, Gorecki DK, Kasian GF. Chloral hydrate disposition following single-dose administration to critically ill neonates and children. Dev Pharmacol Ther. 1991;16(2):71–7.PubMed
47.
Reimche LD, Sankaran K, Hindmarsh KW, Kasian GF, Gorecki DK, Tan L. Chloral hydrate sedation in neonates and infants-clinical and pharmacologic considerations. Dev Pharmacol Ther. 1989;12(2):57–64.PubMed
48.
Pershad J, Palmisano P, Nichols M. Chloral hydrate: the good and the bad. Pediatr Emerg Care. 1999;15(6):432–5.PubMed
49.
American Academy of Pediatrics, Committee on Drugs and Committee on Environmental Health. Use of chloral hydrate for sedation in children. Pediatrics. 1993;92(3):471–3.
Codeine
Dexmedetomidine
53.
Sakurai Y, Obata T, Odaka A, Terui K, Tamura M, Miyao H. Buccal administration of dexmedetomidine as a pre-anesthetic in children. J Anesth. 2010;24(1):49–53.PubMed
54.
Karaaslan D, Peker TT, Alaca A, Ozmen S, Kirdemir P, Yorgancigil H, et al. Comparison of buccal and intramuscular dexmedetomidine premedication for arthroscopic knee surgery. J Clin Anesth. 2006;18(8):589–93.PubMed
55.
Anttila M, Penttilä J, Helminen A, Vuorilehto L, Scheinin H. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol. 2003;56(6):691–3.PubMedPubMedCentral
56.
Penttilä J, Helminen A, Anttila M, Hinkka S, Scheinin H. Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects. Can J Physiol Pharmacol. 2004;82(5):359–62.PubMed
57.
Talon MD, Woodson LC, Sherwood ER, Aarsland A, McRae L, Benham T. Intranasal dexmedetomidine premedication is comparable with midazolam in burn children undergoing reconstructive surgery. J Burn Care Res. 2009;30(4):599–605.PubMed
58.
Yuen VM, Hui TW, Irwin MG, Yuen MK. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth Analg. 2008;106(6):1715–21.PubMed
59.
Yuen VM, Irwin MG, Hui TW, Yuen MK, Lee LH. A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine. Anesth Analg. 2007;105(2):374–80.PubMed
60.
Mason KP, Lubisch NB, Robinson F, Roskos R. Intramuscular dexmedetomidine sedation for pediatric MRI and CT. AJR Am J Roentgenol. 2011;197(3):720–5.PubMed
61.
Mason KP, Lubisch N, Robinson F, Roskos R, Epstein MA. Intramuscular dexmedetomidine: an effective route of sedation preserves background activity for pediatric electroencephalograms. J Pediatr. 2012;161(5):927–32.PubMed
62.
Petroz GC, Sikich N, James M, van Dyk H, Shafer SL, Schily M, et al. A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology. 2006;105(6):1098–110.PubMed
63.
Díaz SM, Rodarte A, Foley J, Capparelli EV. Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: preliminary study. Pediatr Crit Care Med. 2007;8(5):419–24.PubMed
64.
Vilo S, Rautiainen P, Kaisti L, Aantaa R, Scheinin M, Manner T, et al. Pharmacokinetics of intravenous dexmedetomidine in children under 11 years of age. Br J Anaesth. 2008;100(5):697–700.PubMed
65.
Potts AL, Warman GR, Anderson BJ. Dexmedetomidine disposition in children: a population analysis. Paediatr Anaesth. 2008;18(8):722–30.PubMed
66.
Potts AL, Anderson BJ, Warman GR, Lerman J, Diaz SM, Vilo S. Dexmedetomidine pharmacokinetics in pediatric intensive care—a pooled analysis. Paediatr Anaesth. 2009;19(11):1119–29.PubMed
67.
Evers AS, Crowder CM, Balser JR. General anesthetics. In: Brunton LL, Laso JS, Parker KL, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. p. 341–68.
Diazepam
68.
69.
Blumer JL. Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet. 1998;35(1):37–47.PubMed
Etomidate
70.
71.
Sfez M, Le Mapihan Y, Levron JC, Gaillard JL, Rosemblatt JM, Le Moing JP. Comparison of the pharmacokinetics of etomidate in children and in adults. Ann Fr Anesth Reanim. 1990;9(2):127–31.PubMed
72.
Baxter AL, Mallory MD, Spandorfer PR, Sharma S, Freilich SH, Cravero J, et al. Etomidate versus pentobarbital for computed tomography sedations: report from the Pediatric Sedation Research Consortium. Pediatr Emerg Care. 2007;23(10):690–5.PubMed
73.
Di Liddo L, D’Angelo A, Nguyen B, Bailey B, Amre D, Stanciu C. Etomidate versus midazolam for procedural sedation in pediatric outpatients: a randomized controlled trial. Ann Emerg Med. 2006;48(4):433–40, 440.e1.
74.
Kienstra AJ, Ward MA, Sasan F, Hunter J, Morriss MC, Macias CG. Etomidate versus pentobarbital for sedation of children for head and neck CT imaging. Pediatr Emerg Care. 2004;20(8):499–506.PubMed
75.
Cotten JF, Husain SS, Forman SA, Miller KW, Kelly EW, Nguyen HH, et al. Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression. Anesthesiology. 2009;111:240–9.PubMedPubMedCentral
76.
Cotten JF, Forman SA, Laha JK, Cuny GD, Husain SS, Miller KW, et al. Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function. Anesthesiology. 2010;112:637–44.PubMedPubMedCentral
Fentanyl
77.
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/19813s039lbl.pdf. Accessed 14 Dec 2013.
78.
Zernikow B, Michel E, Anderson B. Transdermal fentanyl in childhood and adolescence: a comprehensive literature review. J Pain. 2007;8(3):187–207.PubMed
79.
Finkel JC, Finley A, Greco C, Weisman SJ, Zeltzer L. Transdermal fentanyl in the management of children with chronic severe pain: results from an international study. Cancer. 2005;104(12):2847–57.PubMed
80.
Noyes M, Irving H. The use of transdermal fentanyl in pediatric oncology palliative care. Am J Hosp Palliat Care. 2001;18(6):411–6.PubMed
81.
Hunt A, Goldman A, Devine T, Phillips M; FEN-GBR-14 Study Group. Transdermal fentanyl for pain relief in a paediatric palliative care population. Palliat Med. 2001;15(5):405–12.
82.
Mannerkoski MK, Heiskala HJ, Santavuori PR, Pouttu JA. Transdermal fentanyl therapy for pains in children with infantile neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol. 2001;5(Suppl A):175–7.PubMed
83.
Collins JJ, Dunkel IJ, Gupta SK, Inturrisi CE, Lapin J, Palmer LN, et al. Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. J Pediatr. 1999;134(3):319–23.PubMed
84.
Clotz MA, Nahata MC. Clinical uses of fentanyl, sufentanil, and alfentanil. Clin Pharm. 1991;10(8):581–93.PubMed
85.
Chung S, Lim R, Goldman RD. Intranasal fentanyl versus placebo for pain in children during catheterization for voiding cystourethrography. Pediatr Radiol. 2010;40(7):1236–40.PubMed
86.
Holdgate A, Cao A, Lo KM. The implementation of intranasal fentanyl for children in a mixed adult and pediatric emergency department reduces time to analgesic administration. Acad Emerg Med. 2010;17(2):214–7.PubMed
87.
Cole J, Shepherd M, Young P. Intranasal fentanyl in 1-3-year-olds: a prospective study of the effectiveness of intranasal fentanyl as acute analgesia. Emerg Med Australas. 2009;21(5):395–400.PubMed
88.
Herd D, Borland M. Intranasal fentanyl paediatric clinical practice guidelines. Emerg Med Australas. 2009;21(4):335.PubMed
89.
Borland ML, Clark LJ, Esson A. Comparative review of the clinical use of intranasal fentanyl versus morphine in a paediatric emergency department. Emerg Med Australas. 2008;20(6):515–20. Erratum in: Emerg Med Australas. 2009;21(3):246. (Dosage error in article text).PubMed
90.
Voronov P, Tobin MJ, Billings K, Coté CJ, Iyer A, Suresh S. Postoperative pain relief in infants undergoing myringotomy and tube placement: comparison of a novel regional anesthetic block to intranasal fentanyl–a pilot analysis. Paediatr Anaesth. 2008;18(12):1196–201.PubMed
91.
Ali S, Klassen TP. Intranasal fentanyl and intravenous morphine did not differ for pain relief in children with closed long-bone fractures. Evid Based Med. 2007;12(6):176.PubMed
92.
Wolfe T. Intranasal fentanyl for acute pain: techniques to enhance efficacy. Ann Emerg Med. 2007;49(5):721–2.PubMed
93.
Borland M, Jacobs I, King B, O’Brien D. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med. 2007;49(3):335–40.PubMed
94.
Borland ML, Bergesio R, Pascoe EM, Turner S, Woodger S. Intranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: a randomised double blind cross-over study. Burns. 2005;31(7):831–7.PubMed
95.
Borland ML, Jacobs I, Geelhoed G. Intranasal fentanyl reduces acute pain in children in the emergency department: a safety and efficacy study. Emerg Med (Fremantle). 2002;14(3):275–80.
96.
Manjushree R, Lahiri A, Ghosh BR, Laha A, Handa K. Intranasal fentanyl provides adequate postoperative analgesia in pediatric patients. Can J Anaesth. 2002;49(2):190–3.PubMed
97.
Finkel JC, Cohen IT, Hannallah RS, Patel KM, Kim MS, Hummer KA, et al. The effect of intranasal fentanyl on the emergence characteristics after sevoflurane anesthesia in children undergoing surgery for bilateral myringotomy tube placement. Anesth Analg. 2001;92(5):1164–8.PubMed
98.
Galinkin JL, Fazi LM, Cuy RM, Chiavacci RM, Kurth CD, Shah UK, et al. Use of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesia. Anesthesiology. 2000;93(6):1378–83.PubMed
99.
Mahar PJ, Rana JA, Kennedy CS, Christopher NC. A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries. Pediatr Emerg Care. 2007;23(8):544–8.PubMed
100.
Zernikow B, Michel E, Craig F, Anderson BJ. Pediatric palliative care: use of opioids for the management of pain. Paediatr Drugs. 2009;11(2):129–51.PubMed
101.
Robert R, Brack A, Blakeney P, Villarreal C, Rosenberg L, Thomas C, et al. A double-blind study of the analgesic efficacy of oral transmucosal fentanyl citrate and oral morphine in pediatric patients undergoing burn dressing change and tubbing. J Burn Care Rehabil. 2003;24(6):351–5.PubMed
102.
Howell TK, Smith S, Rushman SC, Walker RW, Radivan F. A comparison of oral transmucosal fentanyl and oral midazolam for premedication in children. Anaesthesia. 2002;57(8):798–805.PubMed
103.
Klein EJ, Diekema DS, Paris CA, Quan L, Cohen M, Seidel KD. A randomized, clinical trial of oral midazolam plus placebo versus oral midazolam plus oral transmucosal fentanyl for sedation during laceration repair. Pediatrics. 2002;109(5):894–7.PubMed
104.
Moore PA, Cuddy MA, Magera JA, Caputo AC, Chen AH, Wilkinson LA. Oral transmucosal fentanyl pre-treatment for outpatient general anesthesia. Anesth Prog. 2000;47(2):29–34.PubMedPubMedCentral
105.
Sharar SR, Carrougher GJ, Selzer K, O’Donnell F, Vavilala MS, Lee LA. A comparison of oral transmucosal fentanyl citrate and oral oxycodone for pediatric outpatient wound care. J Burn Care Rehabil. 2002;23(1):27–31.PubMed
106.
Howell TK, Smith S, Rushman S, Walker RW. A comparison of oral transmucosal fentanyl and oral midazolam for premedication in children. Paediatr Anaesth. 2000;10(6):697.PubMed
107.
Sharar SR, Bratton SL, Carrougher GJ, Edwards WT, Summer G, Levy FH, et al. A comparison of oral trans-mucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil. 1998;19(6):516–21.PubMed
108.
Ginsberg B, Dear RB, Margolis JO, Dear GD, Ross AK. Oral transmucosal fentanyl citrate as an anaesthetic premedication when dosed to an opioid effect vs total opioid consumption. Paediatr Anaesth. 1998;8(5):413–8.PubMed
109.
Dsida RM, Wheeler M, Birmingham PK, Henthorn TK, Avram MJ, Enders-Klein C, et al. Premedication of pediatric tonsillectomy patients with oral trans-mucosal fentanyl citrate. Anesth Analg. 1998;86(1):66–70.PubMed
110.
Weisman SJ, Bernstein B, Schechter NL. Consequences of inadequate analgesia during painful procedures in children. Arch Pediatr Adolesc Med. 1998;152(2):147–9.PubMed
111.
Malviya S, Voepel-Lewis T, Huntington J, Siewert M, Green W. Effects of anesthetic technique on side effects associated with fentanyl Oralet premedication. J Clin Anesth. 1997;9(5):374–8.PubMed
112.
Epstein RH, Mendel HG, Witkowski TA, Waters R, Guarniari KM, Marr AT, et al. The safety and efficacy of oral transmucosal fentanyl citrate for preoperative sedation in young children. Anesth Analg. 1996;83(6):1200–5.PubMed
113.
Schutzman SA, Liebelt E, Wisk M, Burg J. Comparison of oral transmucosal fentanyl citrate and intramuscular meperidine, promethazine, and chlorpromazine for conscious sedation of children undergoing laceration repair. Ann Emerg Med. 1996;28(4):385–90.PubMed
114.
Brenn BR. Side effects with use of oral transmucosal fentanyl. Pediatrics. 1995;96(3 Pt 1):544.PubMed
115.
Schechter NL, Weisman SJ, Rosenblum M, Bernstein B, Conard PL. The use of oral transmucosal fentanyl citrate for painful procedures in children. Pediatrics. 1995;95(3):335–9.PubMed
116.
Friesen RH, Carpenter E, Madigan CK, Lockhart CH. Oral transmucosal fentanyl citrate for preanaesthetic medication of paediatric cardiac surgery patients. Paediatr Anaesth. 1995;5(1):29–33.PubMed
117.
Schutzman SA, Burg J, Liebelt E, Strafford M, Schechter N, Wisk M, et al. Oral transmucosal fentanyl citrate for premedication of children undergoing laceration repair. Ann Emerg Med. 1994;24(6):1059–64.PubMed
118.
Friesen RH, Lockhart CH. Oral transmucosal fentanyl citrate for preanesthetic medication of pediatric day surgery patients with and without droperidol as a prophylactic anti-emetic. Anesthesiology. 1992;76(1):46–51.PubMed
119.
Lind GH, Marcus MA, Mears SL, Ashburn MA, Peterson BJ, Bernhisel KT, et al. Oral transmucosal fentanyl citrate for analgesia and sedation in the emergency department. Ann Emerg Med. 1991;20(10):1117–20.PubMed
120.
Goldstein-Dresner MC, Davis PJ, Kretchman E, Siewers RD, Certo N, Cook DR. Double-blind comparison of oral transmucosal fentanyl citrate with oral meperidine, diazepam, and atropine as preanesthetic medication in children with congenital heart disease. Anesthesiology. 1991;74(1):28–33.PubMed
121.
Ashburn MA, Streisand JB, Tarver SD, Mears SL, Mulder SM, Floet Wilms AW, et al. Oral transmucosal fentanyl citrate for premedication in paediatric out-patients. Can J Anaesth. 1990;37(8):857–66.PubMed
122.
Stanley TH, Leiman BC, Rawal N, Marcus MA, van den Nieuwenhuyzen M, Walford A, et al. The effects of oral transmucosal fentanyl citrate premedication on preoperative behavioral responses and gastric volume and acidity in children. Anesth Analg. 1989;69(3):328–35.PubMed
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
